Posted on June 10, 2008 at 1:43 PM
Filed under: Acquisitions | Divesting and Restructuring | Growth Strategy
Tagged: corporate strategy , CuraScript , divest , Express Scripts , integration , mergers and acquisitions , OptionCare , Walgreens

[ Share ]  [ E-mail ]  [ Leave a Comment ]

Seeking to further expand its home infusion pharmacy division, Walgreen Co. will acquire Express Scripts Inc.'s CuraScript Infusion Pharmacy Inc. for an undisclosed amount. CuraScript provides IV treatments for immune deficiency, chemotherapy and pain management. Express Scripts divested CuraScript because it was a noncore business.

CuraScript will be integrated into Walgreen's home infusion pharmacy division, OptionCare Enterprises Inc. Walgreen  acquired OptionCare Enterprises last July for $850 million in cash. The follow-on deal accelerates Walgreen's move into specialty pharmacy, one of the fastest-growing healthcare segments. Medco Health Solutions Inc. and CVS Caremark Corp. also compete in the field.

WIth 12 facilities in six states, CuraScript augments OptionCare's national coverage. The deal is expected to close in the next 30 days. - Maria Woehr


Join Corporate Dealmaker's LinkedIn forum

Also From Corporate Dealmaker

• Deal Economy 2010: Cisco's Hooper on Tandberg pursuit
• Deal Economy 2010: IBM's Mendoza on IT services M&A
• Next up on mobile ad acquisitions
• Deal Economy 2010: GE's O'Brien on M&A strategy
• Medtronic earnings reflect strategic maneuvering

Corporate Dealmaker Home Page

From TheDeal.com

• Deal Economy 2010: IBM's Mendoza on IT services M&A
• Deal Stocks: GOOG, BMO, C, PLA, GE, FIF, PBCT
• Joost assets quietly sold to Adconion
• Deal Economy 2010: Streambank's Fried on IP valuations
• Green Mountain raises Diedrich bid

TheDeal.com Home

Post a comment

Name:

Email Address:

URL:

Remember personal info?

Comments: (you may use HTML tags for style)

Please only click "Post" once. It may take a few moments to process.